{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:35:04Z","timestamp":1770881704797,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T00:00:00Z","timestamp":1381536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s13181-013-0339-2","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T17:36:04Z","timestamp":1381512964000},"page":"326-338","source":"Crossref","is-referenced-by-count":26,"title":["The Scientific Basis for Chelation: Animal Studies and Lead Chelation"],"prefix":"10.1007","volume":"9","author":[{"given":"Donald","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.","family":"Strupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,12]]},"reference":[{"key":"339_CR1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/clpt.1985.67","volume":"37","author":"JH Graziano","year":"1985","unstructured":"Graziano JH, Siris ES, LoIacono N, Silverberg SJ, Turgeon L (1985) 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication. Clin Pharmacol Ther 37:431\u2013438","journal-title":"Clin Pharmacol Ther"},{"key":"339_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF03259834","volume":"1","author":"JH Graziano","year":"1986","unstructured":"Graziano JH (1986) Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1:155\u2013162","journal-title":"Med Toxicol"},{"issue":"4","key":"339_CR3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3476(88)80396-2","volume":"113","author":"JH Graziano","year":"1988","unstructured":"Graziano JH, Lolacono NJ, Meyer P (1988) Dose\u2013response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr 113(4):751\u2013757","journal-title":"J Pediatr"},{"issue":"1","key":"339_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-3476(05)80618-3","volume":"120","author":"JH Graziano","year":"1992","unstructured":"Graziano JH, Lolacono NJ, Moulton T, Mitchell ME, Slavkovich V, Zarate C (1992) Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 120(1):133\u2013139","journal-title":"J Pediatr"},{"key":"339_CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/clpt.1989.67","volume":"45","author":"HV Aposhian","year":"1989","unstructured":"Aposhian HV, Maiorino RM, Dart RC, Perry DF (1989) Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects. Clin Pharmacol Ther 45:520\u2013526","journal-title":"Clin Pharmacol Ther"},{"key":"339_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.pa.30.040190.001431","volume":"30","author":"HV Aposhian","year":"1990","unstructured":"Aposhian HV, Aposhian MM (1990) Meso-2,3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol 30:279\u2013306","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"339_CR7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0041-008X(89)90094-X","volume":"100","author":"M Rivera","year":"1989","unstructured":"Rivera M, Zheng W, Aposhian HV, Fernando Q (1989) Determination and metabolism of dithiol chelating agents VIII. Metal complexes of meso-dimercaptosuccinic acid. Toxicol Appl Pharmacol 100:96\u2013106","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"339_CR8","first-page":"570","volume":"254","author":"RM Maiorino","year":"1990","unstructured":"Maiorino RM, Akins JM, Blaha K, Carter DE, Aposhian HV (1990) Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation. J Pharmacol Exp Ther 254(2):570\u2013577","journal-title":"J Pharmacol Exp Ther"},{"key":"339_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3476(94)70217-9","volume":"125","author":"RC Dart","year":"1994","unstructured":"Dart RC, Hurlbut KM, Maiorino RM, Mayersohn M, Aposhian HV, Hassen LV (1994) Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. J Pediatr 125:309\u2013316","journal-title":"J Pediatr"},{"issue":"7\u20138","key":"339_CR10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1289\/ehp.95103734","volume":"103","author":"P Asiedu","year":"1995","unstructured":"Asiedu P, Moulton T, Blum CB, Roldan E, Lolacono NJ, Graziano JH (1995) Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. Environ Health Perspect 103(7\u20138):734\u2013739","journal-title":"Environ Health Perspect"},{"key":"339_CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/taap.2000.8973","volume":"166","author":"DR Smith","year":"2000","unstructured":"Smith DR, Woolard D, Luck M, Laughlin N (2000) Succimer and the reduction of tissue lead in juvenile monkeys. Toxicol Appl Pharmacol 166:230\u2013240","journal-title":"Toxicol Appl Pharmacol"},{"key":"339_CR12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1289\/ehp.01109613","volume":"109","author":"J Cremin","year":"2001","unstructured":"Cremin J, Luck M, Laughlin N, Smith DR (2001) Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys. Environ Health Perspect 109:613\u2013620","journal-title":"Environ Health Perspect"},{"key":"339_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/taap.1999.8807","volume":"161","author":"J Cremin","year":"1999","unstructured":"Cremin J, Luck M, Laughlin N, Smith DR (1999) Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure. Toxicol Appl Pharmacol 161:283\u2013293","journal-title":"Toxicol Appl Pharmacol"},{"key":"339_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1289\/ehp.6517","volume":"112","author":"D Stangle","year":"2004","unstructured":"Stangle D, Strawderman M, Smith D, Kuypers M, Strupp B (2004) Reductions in blood lead overestimate reductions in brain lead after repeated succimer regimens in a rodent model of childhood lead exposure. Environ Health Perspect 112:302\u2013308","journal-title":"Environ Health Perspect"},{"key":"339_CR15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jama.1996.03530290033034","volume":"275","author":"HL Needleman","year":"1996","unstructured":"Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB (1996) Bone lead levels and delinquent behavior. JAMA 275:363\u2013369","journal-title":"JAMA"},{"key":"339_CR16","unstructured":"ACCLPP, Report of the Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention. \u201cLow Level Lead Exposure Harms Children: A Renewed Call for Primary Prevention\u201d, January 4, 2012. http:\/\/www.cdc.gov\/nceh\/lead\/ACCLPP\/Final_Document_030712.pdf ."},{"key":"339_CR17","unstructured":"CDC, Response to Advisory Committee on Childhood Lead Poisoning Prevention Recommendations in \u201cLow Level Lead Exposure Harms Children: A Renewed Call of Primary Prevention\u201d. June 7, 2012. http:\/\/www.cdc.gov\/nceh\/lead\/ACCLPP\/CDC_Response_Lead_Exposure_Recs.pdf ."},{"key":"339_CR18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM200105103441902","volume":"344","author":"WJ Rogan","year":"2001","unstructured":"Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J et al (2001) The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med 344:1421\u20131426","journal-title":"N Engl J Med"},{"key":"339_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.114.1.19","volume":"114","author":"KN Dietrich","year":"2004","unstructured":"Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG et al (2004) Treatment of lead-exposed children clinical trial group: effect of chelation therapy on the neuropsychological and behavioral development of lead exposed children after school entry. Pediatrics 114:19\u201326","journal-title":"Pediatrics"},{"issue":"2","key":"339_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1289\/ehp.9263","volume":"115","author":"D Stangle","year":"2007","unstructured":"Stangle D, Smith DR, Beaudin S, Strawderman M, Levitsky D, Strupp B (2007) Succimer chelation improves learning, attention and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure. Env Health Perspect 115(2):201\u2013209","journal-title":"Env Health Perspect"},{"key":"339_CR21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ntt.2006.11.004","volume":"29","author":"S Beaudin","year":"2007","unstructured":"Beaudin S, Stangle D, Smith DR, Levitsky D, Strupp B (2007) Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats. Neurotoxicol Teratol 29:188\u2013202","journal-title":"Neurotoxicol Teratol"},{"key":"339_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/enrs.1998.3854","volume":"78","author":"DR Smith","year":"1998","unstructured":"Smith DR, Bayer LE, Strupp BJ (1998) Efficacy of succimer chelation for reducing brain Pb in rodents. Env Res 78:168\u2013176","journal-title":"Env Res"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-013-0339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-013-0339-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-013-0339-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T17:23:15Z","timestamp":1559582595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-013-0339-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,12]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1007\/s13181-013-0339-2","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,12]]}}}